Baumer

Baumer EBIT CAGR 10Y

The EBIT CAGR (10 Year) of Baumer (BALM4.SA) as of Nov 9, 2026 is 7.64 %. In the previous year, EBIT CAGR (10 Year) was 7.64 % — a change of 0.00% (lower).

EBIT CAGR 10Y

7.64 %

YoY

0.00%

Last updated:

EBIT CAGR (10 Year) of Baumer is 2024 7.64 % . EBIT CAGR (10 Year) of Baumer was 2023 7.64 % . It decreases by 0.00% lower compared to the previous year.

The Baumer EBIT CAGR 10Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 10Y
Date
EBIT CAGR 10Y
Jan 1, 2017
7.64 BRL
Jan 1, 2018
7.64 BRL
Jan 1, 2019
7.64 BRL
Jan 1, 2020
7.64 BRL
Jan 1, 2021
7.64 BRL
Jan 1, 2022
7.64 BRL
Jan 1, 2023
7.64 BRL
Jan 1, 2024
7.64 BRL
The Baumer EBIT CAGR 10Y history
YEAREBIT CAGR 10YYoY
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %0.00%
7.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

EBIT CAGR (10 Year) of Baumer is 7.64 % in 2024.

On Eulerpool you can find the complete historical development of EBIT CAGR (10 Year) Baumer since 2006 – with annual values, charts, and detailed analysis.

The 10-year EBIT CAGR shows the long-term compound annual growth rate of operating earnings.

To evaluate EBIT CAGR (10 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (10 Year).

EBIT CAGR (10 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (10 Year)'s Baumer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Baumer

All Key Metrics — Baumer